Thyrocare Tech.

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE594H01019
  • NSEID: THYROCARE
  • BSEID: 539871
INR
474.40
3.5 (0.74%)
BSENSE

May 20

BSE+NSE Vol: 2.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000893,
    "name": "Thyrocare Tech.",
    "stock_name": "Thyrocare Tech.",
    "full_name": "Thyrocare Technologies Ltd",
    "name_url": "stocks-analysis/thyrocare-tech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "474.40",
    "chg": 3.5,
    "chgp": "0.74%",
    "dir": 1,
    "prev_price": "470.90",
    "mcapval": "7,501.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539871,
    "symbol": "THYROCARE",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE594H01019",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "2.55 lacs",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/thyrocare-tech-1000893-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Thyrocare Technologies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/thyrocare-technologies-ltd-is-rated-buy-3998825",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_mojoScore_3998825.png",
        "date": "2026-05-19 10:10:44",
        "description": "Thyrocare Technologies Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Thyrocare Technologies Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-3986596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_technicaldot_3986596.png",
        "date": "2026-05-12 08:07:30",
        "description": "Thyrocare Technologies Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting cautious optimism for investors in this small-cap healthcare services stock."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3984768",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_technicaldot_3984768.png",
        "date": "2026-05-11 08:02:49",
        "description": "Thyrocare Technologies Ltd has exhibited a notable shift in price momentum, with its shares advancing 3.60% on 11 May 2026 to close at ₹485.45. Despite a recent technical trend adjustment from mildly bullish to sideways, the stock’s performance continues to outpace the broader market, supported by a complex interplay of technical indicators that suggest both caution and opportunity for investors."
      },
      {
        "title": "Thyrocare Technologies Ltd Gains 15.27%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-gains-1527-5-key-factors-driving-the-weeks-rally-3983210",
        "imagepath": "",
        "date": "2026-05-09 13:09:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high with 7.99% surge to Rs.431.95</p>\n                    <p><strong>7 May:</strong> Mixed technical signals amid 6.53% price gain</p>\n                    <p><strong>8 May:</strong> Intraday high with 11.57% surge and gap up opening</p>\n                    <p><strong>8 May:</strong> Mojo Grade upgraded to Buy with score 70.0</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.421.15</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.485.45</div><div class=\"stat-c..."
      },
      {
        "title": "Are Thyrocare Technologies Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-thyrocare-technologies-ltd-latest-results-good-or-bad-3982348",
        "imagepath": "",
        "date": "2026-05-08 19:20:05",
        "description": "Thyrocare Technologies Ltd's latest financial results for the quarter ended March 2026 reflect a notable operational performance, showcasing significant growth in key metrics. The company reported a consolidated net profit of ₹47.12 crore, representing a substantial year-on-year growth of 117.14%. This impressive profit increase is complemented by a revenue figure of ₹223.95 crore, which marks a year-on-year growth of 19.66%. \n\nThe operating margin for this quarter reached 33.53%, indicating operational efficiency and the highest margin recorded to date, up from 30.83% in the previous year. This margin expansion is attributed to improved pricing power and effective cost management strategies. Additionally, the return on equity (ROE) stands at 23.91%, highlighting the company's strong capital efficiency.\n\nThyrocare's performance also indicates a sequential revenue growth of 14.53% from the previous quarter, ..."
      },
      {
        "title": "Thyrocare Technologies Ltd Sees Surge in Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-sees-surge-in-value-trading-and-institutional-interest-3981223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_most_active_equities_by_value_3981223.png",
        "date": "2026-05-08 10:00:25",
        "description": "Thyrocare Technologies Ltd witnessed a remarkable surge in trading activity on 8 May 2026, emerging as one of the most actively traded stocks by value on the Indian equity markets. The healthcare services company recorded a substantial 8.21% gain in a single day, driven by robust institutional participation and a strong order flow that pushed the stock close to its 52-week high. This performance notably outpaced both its sector and the broader Sensex index, signalling renewed investor confidence in the small-cap healthcare player."
      },
      {
        "title": "Thyrocare Technologies Q4 FY26: Stellar Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/thyrocare-technologies-q4-fy26-stellar-profit-surge-masks-valuation-concerns-3981736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_quaterlyResult_3981736.png",
        "date": "2026-05-08 09:51:51",
        "description": "Thyrocare Technologies Ltd., India's leading diagnostic services provider, delivered a remarkable fourth-quarter performance for FY26, with consolidated net profit surging 117.14% year-on-year to ₹47.12 crores, significantly outpacing market expectations. The Mumbai-based company, commanding a market capitalisation of ₹7,908.13 crores, reported its highest-ever quarterly revenue of ₹223.95 crores, representing a 19.66% year-on-year growth and a robust 14.53% sequential improvement."
      },
      {
        "title": "Thyrocare Technologies Ltd Opens 5.62% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-3981101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_gapup_3981101.png",
        "date": "2026-05-08 09:40:48",
        "description": ""
      },
      {
        "title": "Thyrocare Technologies Ltd Surges 11.57% to Day's High of Rs 521 — Outperforms Sector by 11.23 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/thyrocare-technologies-ltd-hits-intraday-high-with-1157-surge-on-8-may-2026-3981039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThyrocareTechno_priceRelatedfactors_3981039.png",
        "date": "2026-05-08 09:31:00",
        "description": "The Sensex declined 0.37% on 08 Jun 2026 while Thyrocare Technologies Ltd surged 11.57%, marking a remarkable 11.23-percentage-point outperformance over its Healthcare Services sector. This strong single-session gain rewrites the short-term narrative for the stock, which has been on a notable upward trajectory in recent days."
      }
    ],
    "total": 323,
    "sid": "1000893",
    "stock_news_url": "https://www.marketsmojo.com/news/thyrocare-technologies-1000893"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "14-May-2026",
      "details": "Please find attached the Earnings Call Transcript held on May 12 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "12-May-2026",
      "details": "Please find attached herewith Link of Audio Recording for Investor Call held on May 12 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-May-2026",
      "details": "Please find attached herewith Newspaper Publications of Audited Financial Results for the quarter and financial year ended on March 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has declared <strong>70%</strong> dividend, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Thyrocare Technologies Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 28 Nov 25",
          "dt": "2025-11-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Thyrocare Technologies Ltd Gains 15.27%: 5 Key Factors Driving the Week’s Rally

2026-05-09 13:09:45

Key Events This Week

4 May: Intraday high with 7.99% surge to Rs.431.95

7 May: Mixed technical signals amid 6.53% price gain

8 May: Intraday high with 11.57% surge and gap up opening

8 May: Mojo Grade upgraded to Buy with score 70.0

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

14-May-2026 | Source : BSE

Please find attached the Earnings Call Transcript held on May 12 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

12-May-2026 | Source : BSE

Please find attached herewith Link of Audio Recording for Investor Call held on May 12 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

09-May-2026 | Source : BSE

Please find attached herewith Newspaper Publications of Audited Financial Results for the quarter and financial year ended on March 31 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Thyrocare Technologies Ltd has declared 70% dividend, ex-date: 24 Oct 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Thyrocare Technologies Ltd has announced 2:1 bonus issue, ex-date: 28 Nov 25

stock-summary
RIGHTS

No Rights history available